Food and Drug Administration shortage and compounding guidance (2024 to 2026), including the April 30, 2026 proposed 503B bulks list exclusion and public comment period
Maintaining weight loss after GLP-1 therapy is one of the most actively researched topics in obesity medicine right now
For research and laboratory use only, not for human consumption unless prescribed Drug Type Other, Peptide Other, Peptide Hormone Ingredients BPC-157 (Body Protection Compound-157) GHRP-6 (Growth Hormone Releasing Peptide-6) Physical Form Other, Lyophilized Powder Other, Lyophilized Powder Function Other, Supports tissue regeneration, accelerates healing, reduces inflammation
Used Infrequently Glutathione N.B
Ingredients Filtered Water, Phosphoric Acid, Citric Acid, Malic Acid, Natural Flavor, Sucralose, Acesulfame Potassium, Potassium Sorbate (Preservative), Sodium Benzoate (Preservative) Allergen Warning Manufactured in a facility which processes Milk, Eggs, Fish, Shellfish, Tree Nuts, Peanuts, Wheat, Soybeans, and Sesame
People with lower levels of L-carnitine, such as vegetarians, vegans, and older adults, can benefit from supplements